Vestar, Inc.

Basic Information

650 Cliffside Drive
San Dimas, CA, 91773

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Liposomal TNF¿Potential Application as Cancer Therapy

    Amount: $596,469.00

    Preliminary findings indicate that liposomal tumor necrosis factor (TNF) has potential application as an anti-tumor therapy. In initial studies, it retains cytotoxic activity against cancer cells in c ...

    SBIR Phase II 1995 Department of Health and Human Services
  2. Selectively Modified Tumor Necrosis Factor

    Amount: $50,000.00

    Genes for selectively modified tumor necrosis factor (SM-TNF) will be used to produce sufficient quantities of the proteins for testing. To accomplish this goal, the genes for TNF-alpha and TNF-beta w ...

    SBIR Phase I 1993 Department of Health and Human Services
  3. Liposomal TNF¿Potential Application as Cancer Therapy

    Amount: $50,000.00

    N/A

    SBIR Phase I 1993 Department of Health and Human Services
  4. IL-2 LIPOSOMES AS DELIVERY AGENTS FOR IMMUNOTHERAPEUTICS

    Amount: $47,838.00

    VESTAR HAS DEVELOPED A LIPOSOMAL DRUG DELIVERY SYSTEM COMPRISED OF (MTX) ENCAPSULATED IN THE INTERNAL AQUEOUS SPACE OF SMALL UNILAMELLAR VESICLES AND HUMAN RECOMBINANT IL-2 COVALENTLY COUPLED TO THE E ...

    SBIR Phase I 1991 Department of Health and Human Services
  5. LIPOSOMAL GOLD COMPOUNDS\IMPROVED ANTIARTHRITIC THERAPY

    Amount: $46,571.00

    CONJUGATED GOLD COMPOUNDS SUCH AS AUROTHIOMALATE, ARE ADMINISTERED IN PROGRESSIVE RHEUMATOID ARTHRITIS. AT PRESENT, ONLY THESE ANTIARTHRITICS ARREST THE PROGRESSION OF THE DISEASE. TREATMENT IS LIMITE ...

    SBIR Phase I 1991 Department of Health and Human Services
  6. LYOPHILIZATION OF LIPOSOME ENCAPSULATED HEMOGLOBIN

    Amount: $500,000.00

    VESTAR PROPOSES TO DEVELOP THE METHODS NECESSARY TO LYOPHILIZE LIPOSOME ENCAPSULATED HEMOGLOBIN (IEH) . THE METHODS AND EQUIPMENT UTILIZED WILL BE COMMENSURATE WITH LARGE-SCALE LYOPHILIZATION PRACTICE ...

    SBIR Phase II 1991 NavyDepartment of DefenseDepartment of Defense
  7. LYOPHILIZATION OF LIPOSOME ENCAPSULATED HEMOGLOBIN

    Amount: $50,000.00

    N/A

    SBIR Phase I 1991 NavyDepartment of DefenseDepartment of Defense
  8. IMMUNOLIPOSOME DELIVERY OF CHEMOTHERAPEUTICS

    Amount: $50,000.00

    THIS PROJECT WILL DEVELOP MONOCLONAL ANTIBODY-TARGETED LIPOSOMES FOR THE PURPOSE OF DELIVERING CHEMOTHERAPEUTIC AGENTS. MONOCLONAL ANTIBODY RAISED AGAINST A TUMOR-SPECIFICSURFACE ANTIGEN WILL BE COVAL ...

    SBIR Phase I 1990 Department of Health and Human Services
  9. LIPOSOME-ENCAPSULATED B-10 FOR NEUTRON CAPTURE THERAPY

    Amount: $50,000.00

    NEUTRON CAPTURE THERAPY IS AN ATTRACTIVE ALTERNATIVE TO STANDARD RADIATION TECHNIQUES FOR CANCER TREATMENT IF NUCLEI, SUCH AS (10)B, CAN BE SELECTIVELY CONCENTRATED IN TUMORS. SMALL, UNILAMELLAR, PHOS ...

    SBIR Phase I 1987 Department of Health and Human Services
  10. ACUTE MYOCARDIAL INFARCTION ACCOUNTS FOR APPROXIMATELY 700,000 HOSPITALIZATIONS ANNUALLY.

    Amount: $50,000.00

    ACUTE MYOCARDIAL INFARCTION ACCOUNTS FOR APPROXIMATELY 700,000 HOSPITALIZATIONS ANNUALLY. ONE THERAPEUTIC APPROACHTO THIS PROBLEM IS THE APPLICATION OF THROMBOLYTIC AGENTS, SUCH AS STREPTOKINASE, TO P ...

    SBIR Phase I 1986 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government